NIT
IONS icon

NumerixS Investment Technologies’s Ionis Pharmaceuticals IONS Stock Holding History

NumerixS Investment Technologies’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,200
Closed -$141K – 1117
2019
Q2 		$141K Buy
+2,200
New +$156K 0.04% 501
2018
Q4 		– Sell
-3,615
Closed -$187K – 1221
2018
Q3 		$187K Buy
+3,615
New +$170K 0.04% 607
2018
Q2 		– Sell
-7,600
Closed -$349K – 1232
2018
Q1 		$349K Buy
+7,600
New +$386K 0.09% 263
2015
Q4 		– Sell
-28,670
Closed -$1.16M – 816
2015
Q3 		$1.16M Buy
+28,670
New +$1.48M 0.13% 191
2015
Q2 		– Sell
-13,740
Closed -$875K – 691
2015
Q1 		$875K Buy
13,740
+10,279
+297% +$697K 0.16% 174
2014
Q4 		$214K Buy
+3,461
New +$171K 0.07% 399

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

NumerixS Investment Technologies's IONS Position: Q3 2019 in Review

NumerixS Investment Technologies sold out of Ionis Pharmaceuticals (IONS) in Q3 2019, closing a stake of 2,200 shares — an estimated $141K sold.

NumerixS Investment Technologies first reported a position in IONS in Q4 2014 and held it in 6 quarters. The position peaked at $1.16M in Q3 2015. 369 funds tracked by Wall St. Rank hold IONS as of Q3 2019.

  • NumerixS Investment Technologies reported no remaining Ionis Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 2,200 Ionis Pharmaceuticals shares in Q3 2019, an estimated $141K.
  • NumerixS Investment Technologies first reported a position in Ionis Pharmaceuticals in Q4 2014 and held it in 6 quarters.
  • NumerixS Investment Technologies's Ionis Pharmaceuticals position peaked at $1.16M in Q3 2015.
  • 369 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2019.

Based on NumerixS Investment Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.